Selectis Health (GBCS) Invested Capital (2011 - 2025)

Selectis Health's Invested Capital history runs 15 years deep, the most recent figure standing at $7.2 million for Q4 2025.

• In Q4 2025, Invested Capital fell 47.55% year-over-year to $7.2 million; the TTM figure through Dec 2025 stood at $7.2 million (down 47.55% YoY), while the FY2025 annual figure was $7.2 million, down 47.55% from the prior year.
• Invested Capital came in at $7.2 million for Q4 2025 at Selectis Health, down from $12.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $22.2 million in Q4 2023 to a low of $1.4 million in Q3 2023.
• A 5-year average of $9.0 million and a median of $7.7 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slumped 90.57% in 2021 and surged 583.54% in 2023, its largest moves.
• Selectis Health's Invested Capital stood at $9.4 million in 2021, then tumbled by 65.48% to $3.2 million in 2022, then soared by 583.54% to $22.2 million in 2023, then slumped by 38.22% to $13.7 million in 2024, then tumbled by 47.55% to $7.2 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $7.2 million, $12.9 million, and $12.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison